原文はこちら

Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab

(Intern Med. 2023 Apr 7. doi: 10.2169/internalmedicine.1642-23. Online ahead of print.)

https://pubmed.ncbi.nlm.nih.gov/37032080/